Clinical trials
Phase 2 Thyroid Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National University Hospital, Singapore | 2 |
| Apollomics Inc. | 1 |
| Bayer | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 5 |
| Salivary Gland Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Medullary | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Glioblastoma | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.